Ms. Cadoret-Manier is executive vice president, chief global product strategy and operations officer at Ionis Pharmaceuticals. She is a member of Ionis’ executive leadership team, overseeing the company’s portfolio planning, global product strategy, medical affairs, market access and commercial strategy and operations functions. With 30 years of experience in life sciences, Ms. Cadoret-Manier is leading Ionis’ drive to integrate medical and commercial functions into the company.
She joined Ionis in 2020 as chief corporate development and commercial officer, where she led business development and commercial functions. Prior to Ionis, Ms. Cadoret-Manier was the chief commercial officer for Grail Biosciences, where she developed and executed a commercial strategy to prepare for the first ever early detection cancer screening test. She was previously vice president of the Respiratory Franchise at Genentech, where she built and managed a team of more than 400 employees responsible for commercializing medicines that generated $3 billion in revenue. She has held senior management positions overseeing corporate strategy, business development, alliances and marketing and sales for Genentech, Pfizer and Amylin Pharmaceuticals.
She has an MBA from the University of Chicago and a bachelor’s degree in economics from Queens College.